Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
788.60B | 795.27B | 851.96B | 733.01B | 551.29B | 508.25B | Gross Profit |
277.89B | 266.30B | 316.52B | 286.16B | 192.99B | 182.16B | EBIT |
142.28B | 141.92B | 191.36B | 183.24B | 112.51B | 88.35B | EBITDA |
190.75B | 190.92B | 240.55B | 230.32B | 157.62B | 134.26B | Net Income Common Stockholders |
131.64B | 133.16B | 170.59B | 155.27B | 94.01B | 73.37B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
578.70B | 539.08B | 529.23B | 601.22B | 586.78B | 532.56B | Total Assets |
1.95T | 1.93T | 1.87T | 1.78T | 1.63T | 1.51T | Total Debt |
7.62B | 6.42B | 5.11B | 2.44B | 2.16B | 1.82B | Net Debt |
-554.99B | -522.98B | -471.85B | -572.22B | -575.76B | -513.18B | Total Liabilities |
156.57B | 206.84B | 245.98B | 234.09B | 189.64B | 149.63B | Stockholders Equity |
1.73T | 1.71T | 1.62T | 1.54T | 1.43T | 1.36T |
Cash Flow | Free Cash Flow | ||||
33.80B | 117.88B | 52.44B | 91.22B | 96.23B | 69.44B | Operating Cash Flow |
48.28B | 171.76B | 99.50B | 125.58B | 118.00B | 144.87B | Investing Cash Flow |
10.10B | -13.56B | -78.00B | -53.93B | -16.77B | -84.32B | Financing Cash Flow |
-33.41B | -122.51B | -127.92B | -89.15B | -53.13B | -140.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $127.45B | 32.88 | 20.84% | 1.28% | 7.00% | 16.84% | |
77 Outperform | $72.96B | 21.92 | 107.62% | 2.43% | -1.85% | 12.04% | |
76 Outperform | $85.73B | 25.82 | 27.16% | 1.07% | -0.23% | 22.41% | |
73 Outperform | $71.15B | 30.19 | 9.82% | 1.67% | 6.49% | 24.14% | |
68 Neutral | $36.66B | 40.95 | 25.86% | 1.61% | -11.19% | -22.50% | |
66 Neutral | $4.52B | 12.34 | 5.41% | 3.62% | 4.15% | -12.18% | |
63 Neutral | $24.47B | 25.50 | 8.51% | 1.47% | -5.02% | 6.69% |